Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
Kappa-Opioid Settings: Real-World Evidence Insights
CKD-aP Treatment Tool Kit
The Patient-Clinician Connection in Managing CKD-aP
Quantifying CKD-aP: Tools for Better Care
CKD-aP: Beyond the Surface
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Ellie Kelepouris, MD, FACP, FAHA
Potassium Binders in Practice: Clinical Trial Evidence
Patrick Rossignol, MD, PhD
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Javed Butler, MD, MPH, MBA
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD, FACC
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD